Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Ain Pharmaciez: Sales, Profits Show Double-digit Increases
January 21, 2002
- BDJ: BD Eclipse, Needles to Reduce Needle Stick Injuries
January 21, 2002
- Suzuken to Create New MS Image Using IT
January 21, 2002
- Hyogo's Drugstore Chain Maruzen Aims at Sales of \40 Bil.
January 21, 2002
- LDP to Create Panel to Discuss PAL
January 21, 2002
- Toho to Make Funabashi a 100%-Subsidiary
January 21, 2002
- Sumitomo Heavy Industries, GEYMS: FDG MicroLab
January 21, 2002
- Korosho to Make Full Effort to Develop Strong Drug Industry
January 21, 2002
- JPMA to Propose New NHI Drug Price System: JPMA President
January 21, 2002
- OTC NEWS IN BRIEF
January 21, 2002
- Drug Misuse Cases Reach 108 in 2000 with 12 Requiring Hospitalization
January 21, 2002
- Merck Hoei Aiming at Becoming No. 1 Generic House
January 21, 2002
- Private Advisory Board to Mull Medical Fee System to Be Set Up: Health Minister Sakaguchi
January 21, 2002
- BUSINESS NEWS IN BRIEF
January 21, 2002
- BULLETIN
January 14, 2002
- REGULATORY NEWS IN BRIEF
January 14, 2002
- WORLD NEWS IN BRIEF
January 14, 2002
- Lipitor Shows Highest Growth in Sales: Top 100 Drugs
January 14, 2002
- DIAGNOSTIC NEWS IN BRIEF
January 14, 2002
- Otsuka Licenses Drug for Vitreous Body Hemorrhage from ISTA
January 14, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…